Reuters logo
BRIEF-Eiger BioPharma announces sale of non-strategic assets to Theragene Pharma
2017年6月29日 / 中午12点12分 / 4 个月内

BRIEF-Eiger BioPharma announces sale of non-strategic assets to Theragene Pharma

June 29 (Reuters) - Eiger BioPharmaceuticals Inc:

* Eiger BioPharmaceuticals announces sale of non-strategic assets to Theragene Pharmaceuticals

* Eiger BioPharmaceuticals Inc - financial terms of agreement include a total upfront of $3.1 million in payments from Theragene to Eiger

* Eiger BioPharmaceuticals Inc - additional financial terms are not being disclosed

* Eiger BioPharmaceuticals Inc - Theragene has committed to repurchase $1.35 million of common stock paid to Eiger upon closing of a financing raise of $4 million or more

* Eiger BioPharmaceuticals Inc - financial terms of agreement include expense reimbursement in addition to $2.85 million in Theragene common stock

* Eiger BioPharmaceuticals Inc - financial terms of agreement include pre-specified clinical, regulatory milestones totaling $15 million, royalties on net sales, sublicensing milestone fees Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below